Keyphrases
COVID-19
76%
Echocardiographic
69%
ST-elevation Myocardial Infarction (STEMI)
66%
Brugada Syndrome
65%
Acute Kidney Injury
44%
Prognostic Implications
43%
Echocardiography
43%
Myocardial Infarction Patients
42%
Left Ventricular Function
41%
Transcatheter Aortic Valve Implantation
40%
Degenerative Mitral Regurgitation
37%
Clinical Outcomes
36%
Consecutive Patients
34%
Lung Ultrasound
33%
Tricuspid Regurgitation
33%
Right Ventricular Function
33%
Transcatheter Aortic Valve Replacement
32%
Polymorphic Ventricular Tachycardia
32%
Systolic Dysfunction
27%
COVID-19 Patients
25%
Israeli
25%
Long-term Mortality
24%
Post-procedural
21%
QT Interval
21%
Diastolic Dysfunction
20%
Primary Percutaneous Coronary Intervention
20%
Confidence Interval
19%
Tertiary Care Hospital
19%
Percutaneous Coronary Intervention
19%
High Risk
19%
Echocardiographic Evaluation
19%
Odds Ratio
19%
Risk Stratification
18%
Left Ventricular Ejection Fraction
18%
Quinidine
18%
Lung Ultrasound Score
17%
Echocardiographic Parameters
17%
Congenital Long QT Syndrome
17%
Atrial Fibrillation
17%
Pacemaker Implantation
16%
Hazard Ratio
16%
Modified Early Warning Score
16%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
16%
Coronary Artery Disease
16%
Long QT Syndrome Type 3
16%
Ranolazine
16%
Event Data
16%
Torsades Des Pointes
16%
Physician Assistant
16%
Predictive Role
16%
Medicine and Dentistry
COVID-19
100%
Percutaneous Aortic Valve Replacement
72%
Echocardiography
53%
ST Segment Elevation Myocardial Infarction
49%
Tricuspid Insufficiency
41%
Brugada Syndrome
40%
Infection
37%
Lung
34%
Mitral Insufficiency
32%
Systolic Dysfunction
28%
Diastolic Dysfunction
21%
Cardiac Dysrhythmia
20%
Acute Kidney Injury
20%
Percutaneous Coronary Intervention
19%
Stroke Volume
19%
Electrocardiogram
17%
Myocardial Infarction
17%
Pacemaker Implantation
17%
Implantable Automatic Defibrillator
17%
Disease Course
17%
Prevalence
16%
Permanent Pacemaker
16%
Hazard Ratio
16%
Heart Left Ventricle Function
16%
Cardiovascular System
16%
Ejection Fraction
16%
Polymorphic Ventricular Tachycardia
16%
Malignant Neoplasm
16%
Emergency Department
16%
Meta-Analysis
16%
Omicron Coronavirus Variant
16%
Troponin
15%
Risk Stratification
15%
Diastolic Function
15%
Heart Left Ventricle Ejection Fraction
15%
All Cause Mortality
14%
Photoelectric Plethysmography
14%
Odds Ratio
14%
Congestive Heart Failure
13%
Multivariate Analysis
12%
Ventricular Fibrillation
12%
Left Ventricle
12%
Heart Arrest
12%
Mortality Rate
11%
Primary Percutaneous Coronary Intervention
11%
Computed Tomography Angiography
11%
Cardiac Computed Tomography
11%
Biological Marker
11%
Drug-Eluting Stent
11%
Heart Right Ventricle Function
11%
